Why choose mVASC, our newest Orthobiologic complement?
When healing injured or aging tissue, two primary concepts come into play: the availability of key player cells and proteins and adequate blood flow to the affected area. The first concept revolves around supplying the necessary cells and proteins. In contrast, the second focuses on ensuring these elements reach the target area via improved blood flow.
The goal of these healing methods, often referred to as “longevity,” “regeneration,” or “rejuvenation,” is to provide long-term solutions rather than temporary fixes like steroids. For years, treatments like Platelet Rich Plasma (PRP), Alpha 2 Macroglobulin (A2M), amniotic derived growth factors (“stem cells”), autologous exosomes, bone marrow harvest, lipoharvest, shockwave therapy, needling, and cupping have been utilized to introduce key cells and proteins to promote healing.
Many of these methods can effectively heal when administered by an experienced clinician and specifically chosen for each individual depending on their needs. At Full Circle, we will continue to use many of the techniques and now have the added complement of mVASC. This is an additional angle to approach an individual’s care more comprehensively.
Introducing mVASC for More Complete Healing
Recently, attention has shifted to the importance of sustained blood flow in healing. Traditional methods may provide a one-time boost, but how can we ensure continuous delivery of healing properties? The answer lies in increasing microvasculature, also known as “angiogenesis.”
At Full Circle, we adopt a comprehensive approach, targeting both essential healing concepts to achieve a complete and long-lasting recovery. We stimulate cells and proteins using PRP, A2M, exosomes, and focused shockwave therapy while also enhancing blood flow with focused shockwave therapy and mVASC.
What is mVASC?
mVASC is a donor-derived microvascular tissue designed to support the repair of injured or aging tissue. This product contains microscopic arterioles, capillaries, venules, and extracellular matrix, which combines with your body’s microvasculature to create more channels for increased local blood flow to the area in need. Like bone grafts used in fractures or spinal fusions or donor tendon transfers, mVASC integrates donated microscopic blood vessels to combine with yours to promote healing.
How Does mVASC Work?
mVASC integrates with your host tissue through natural healing and remodeling processes. It contains essential components for repairing damaged microvascular tissue, which is crucial for the exchange of liquids and solids in all tissues. Microvascular tissue’s extracellular matrix (ECM) provides binding sites for cell attachment. It supports new vessel formation, leading to a more quickly reestablished circulatory system. This ultimately helps attain the healing that your tissues may need.
How is mVASC Obtained?
Our provider of mVASC, Microvascular Tissues, Inc. (MVT), uses proprietary methods to minimally manipulate donated human cadaveric tissue, ensuring the microvascular structure remains intact and effective.
Is mVASC Safe?
Yes, mVASC is sourced from cadaveric donors who have been screened and tested according to FDA and AATB requirements. It is terminally sterilized and contains no live cells. The U.S. Food and Drug Administration (FDA) regulates mVASC as human tissue for transplantation, ensuring it meets all safety standards. It has been FDA approved since 2015.
mVASC: A Revolutionary New Approach
mVASC represents a groundbreaking advancement in the field of musculoskeletal longevity. While many regenerative treatments have been developed over the years, mVASC is unique in its ability to enhance microvascular tissue, thereby significantly improving blood flow to the affected area. This novel approach addresses a critical aspect of healing that has often been overlooked in traditional treatments.
Why mVASC is Revolutionary
- Innovative Technology: mVASC leverages cutting-edge techniques to harvest and prepare microvascular tissue, setting a new standard in regenerative medicine.
- Enhanced Healing: By promoting angiogenesis, mVASC ensures a continuous supply of essential nutrients and oxygen to the injured tissue, facilitating superior healing.
- Minimally Invasive: Unlike many other treatments that require extensive surgery, mVASC is administered through a simple injection, reducing recovery time and risk.
- Comprehensive Care: mVASC is part of a holistic treatment plan that addresses both cellular regeneration and blood flow enhancement, providing a more complete healing solution.
mVASC for Orthopedics: A Powerful Non-Surgical Alternative
For many patients, mVASC offers an effective non-surgical alternative to traditional orthopedic procedures. Orthopedic surgery can be invasive, requiring lengthy recovery times and posing risks associated with surgical interventions. mVASC provides a minimally invasive option that can help regenerate tissue and improve healing without the need for surgery.
Benefits of mVASC in Orthopedics
- Minimally Invasive: mVASC is administered through a simple injection, eliminating the need for incisions and extensive recovery.
- Faster Recovery: Patients experience quicker relief and faster healing than with surgical options.
- Reduced Pain: The procedure is less painful than surgical interventions and has less possibility for post-procedure complications.
- Effective for Various Conditions: mVASC can treat a wide range of orthopedic issues, including tendon injuries, joint degeneration, and other musculoskeletal problems.
- Lower Risk: With no pro-inflammatory stage and reduced risk of complications, mVASC is a safe option for many patients.
Orthopedic Conditions Treated by mVASC
Meniscus Tears: mVASC can promote healing and stability of the meniscus, reducing pain and improving joint function.
Ligament Injuries: This treatment may assist in the healing of ligament injuries, such as anterior cruciate ligament (ACL) tears, by enhancing tissue repair and integration.
Cartilage Damage: mVASC can be beneficial for patients with cartilage degeneration and injuries as it has been shown to delay cartilage degeneration and as a result, can help stave off joint surgery or replacement.
Tendon Injuries: Conditions like rotator cuff tears or Achilles tendon injuries are ideal indications for mVASC treatment, which supports the healing of damaged tendons.
Bone Fractures: mVASC may support the healing process in complex fractures, especially those that are slow to heal.
Joint Instability: For patients with chronic joint instability, mVASC can help stabilize the joint environment and promote healing of the surrounding tissues.
How mVASC is Different
mVASC offers a revolutionary approach to treating a torn meniscus by promoting natural healing and regeneration. Here’s how it compares to other treatments:
- Physical Therapy: While physical therapy can help strengthen muscles around the knee, it does not repair the torn meniscus. mVASC, however, supports the regeneration of the meniscus tissue by enhancing blood flow and supplying essential cells and proteins.
- Steroid Injections: Steroid injections reduce inflammation and pain but do not promote long-term healing. mVASC provides a continuous flow of healing properties, leading to sustained recovery and regeneration.
- Surgery: Meniscus surgery involves removing or repairing the torn tissue, which can lead to prolonged recovery times and potential complications. mVASC is minimally invasive, involving a simple injection that supports natural healing without the risks associated with surgery.
How is mVASC Administered?
mVASC is a dehydrated cadaveric derived wafer mixed with a local anesthetic. The reconstituted wafer is injected in liquefied form into the injured or aging tissue using ultrasound guidance. The entire procedure takes about 20-30 minutes, and compression is usually applied for a few days.
What to Expect
Unlike PRP and A2M, mVASC does not induce a pro-inflammatory stage, leading to quicker relief and faster recovery. Any soreness experienced is typically due to the injection itself, not the product. Patients report less pain and easier recovery compared to other treatments. We recommend relative rest for the first week, with a 25% increase in activity each subsequent week. Full healing effects can take 6-8 weeks. We often combine PRP and A2M with mVASC therapy for more complete healing and a better chance at regeneration, rejuvenation, and longevity.
One of the key advantages of mVASC treatment is its potential for tissue regeneration rather than removal which keeps your body whole. This is particularly beneficial for active individuals or athletes who wish to maintain joint integrity and reduce the risk of future surgery. The integration process of the mVASC scaffold with the native meniscus tissue can be monitored through follow-up MRI scans, typically scheduled at intervals such as 3 and 6 months post-procedure.
Patients may experience significant improvements in range of motion and pain reduction within 6-8 weeks of the procedure. Depending on the individual case and adherence to the post procedure care, many patients gradually return to their normal activities with relative ease.
Long-term outcomes of mVASC treatment can include full functionality without pain during regular activities, even for high-impact sports like running.
The Next Step Towards More Complete Healing
If you are experiencing one of the vast musculoskeletal conditions that mVASC can potentially improve and are interested in mVASC treatment in Phoenix, contact us via call or text to set up a visit. During your visit, we will take our time discussing your specific issue to determine which treatments are best for you.
We look forward to observing your long-lasting healing and return to the activities you love.